291 results match your criteria: "Clalit Research Institute[Affiliation]"
Genet Med
September 2025
Braun School of Public Health and Community Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel. Electronic address:
J Crohns Colitis
August 2025
Industrial Engineering and Management, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Objectives: In this nationwide study, we used the epi-Israeli Inflammatory Bowel Disease (IBD) Research Nucleus (IIRN) validated cohort to explore the utility of routine blood tests as markers predicting IBD occurrence years before diagnosis.
Methods: We included all health maintenance organization (HMO)-insured IBD patients in Israel diagnosed during 2005-2020 to identify discriminative results of blood tests performed up to 15 years before diagnosis. Each patient was individually matched to two non-IBD controls.
J Public Health (Oxf)
July 2025
Clalit Research Institute, Innovation Division, Clalit Health Services, Ramat Gan, 6578898, Israel.
Background: The Clalit Active Cohort Study (CACS) assess the impact of lifestyle factors, particularly physical activity, on short- and long-term health outcomes using real-world data. Launched in January 2021, CACS focuses on Clalit Health Services members with supplemental health insurance who use the Clalit Active smartphone app.
Methods: The study integrates data from the Clalit Active app with electronic health records from CHS, covering primary and secondary care, hospitalizations, medications, laboratory results, and imaging.
Genet Med
July 2025
Clalit Research Institute, Innovation Division, Clalit Health Services, Ramat Gan, Israel; Gray Faculty of Medicine& Health Sciences, Tel Aviv University, Tel Aviv, Israel; The Ivan and Francesca Berkoviz Family Living Laboratory Collaboration at Harvard Medical School and Clalit Research Institute,
Purpose: The increasing demand for genetic testing and a global shortage of geneticists has significantly strained health care systems worldwide. This highlighted the need for new strategies aiming to increase testing accessibility, reduce wait times, and enhance patient care quality.
Methods: We implemented a 4-step program, "Genetics First," to empower nongeneticist physicians (NGPs) to play an active role in the process of genetic consultation and testing.
Int J Mol Sci
June 2025
The Department of Physiology and Cell Biology, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva 8410501, Israel.
HIKESHI-related hypomyelinating leukodystrophy (HHL) is a life-threatening disorder caused by homozygous pathogenic variants in . Symptoms include infantile onset progressive spastic dystonic quadriplegia, nystagmus, failure to thrive, diffused hypomyelination, and severe morbidity or death following febrile illness. V54L variants in are particularly prevalent within the Ashkenazi Jewish population.
View Article and Find Full Text PDFBr J Haematol
August 2025
Innovation Division, Clalit Health Services, Clalit Research Institute, Tel Aviv-Yafo, Israel.
Multiple myeloma evolves unnoticed over years, and when diagnosed, organ damage is common. Electronic health records (EHR) can help in developing predictive models identifying 'healthy' people at risk. MM patients from Clalit Health Services (2002-2019) were matched with healthy controls.
View Article and Find Full Text PDFCrohns Colitis 360
April 2025
Department of General Surgery, The Eisenberg R&D Authority, Shaare Zedek Medical Center, Jerusalem, Israel.
Background: In this nationwide study, we aimed to explore healthcare services utilization, medical management, and disease outcomes of inflammatory bowel diseases (IBD) across the 2 major ethnic groups in Israel.
Methods: We utilized a cohort including all patients diagnosed with IBD in Israel since 2005. The primary outcome was steroid dependency, with secondary outcomes including use of biologics, time to surgery, and hospitalizations.
Genet Med
July 2025
Raphael Recanati Genetic Institute, Rabin Medical Center-Beilinson Hospital, Petach Tikva, Israel; Ultrasound Unit, Helen Schneider Women's Hospital, Rabin Medical Center, Petah Tikva, Israel. Electronic address:
Purpose: FMR1 premutation has been inconsistently associated with neuropsychiatric phenotypes, possibly because of ascertainment bias. We investigated the association between FMR1 premutation and attention deficit hyperactivity disorder (ADHD), anxiety, and other psychiatric disorders in large-scale population-based genetic carrier screening data.
Methods: We defined premutation as having 58 to 200 CGG repeats.
Eur Geriatr Med
June 2025
Department of Orthopaedic Surgery, Meir Medical Center Affiliated with the Faculty of Health Sciences and Medicine, Tel Aviv University, 59 Tchernichovsky St., kfar-Saba, Israel.
Purpose: This study aimed to evaluate the effectiveness of the PaLMe concept, which incorporates paired exercises into rehabilitation for old patients recovering from hip fracture surgery, and to assess the feasibility of implementing an online rehabilitation program in this population.
Methods: A prospective, randomized interventional study was conducted in a hospital setting. A total of 93 participants (mean age: 80.
Commun Med (Lond)
March 2025
Clalit Research Institute, Innovation Division, Clalit Health Services, Ramat Gan, Israel.
Background: The lack of effective tools available to health providers for enhancing patient physical activity prompts this study to examine the real-world impact of a physical activity reward-driven app on health outcomes, utilizing Electronic Health Records (EHR) data from Israel's largest healthcare organization.
Methods: Conducting a retrospective cohort study, we matched app-users to non-users based on demographic and clinical characteristics.
Results: App-users have a significantly lower risk of cardiovascular disease (HR 0.
Lancet Infect Dis
July 2025
Department of Infectious Diseases and Critical Care Medicine, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Berlin, Germany. Electronic addr
Background: More than 115 000 cases of mpox have been confirmed since the onset of a global outbreak in 2022. In addition to global transmission of clade II monkeypox virus (MPXV), the recent spread of clade I has caused a Public Health Emergency of International Concern. The third-generation smallpox vaccine modified vaccinia Ankara-Bavarian Nordic (MVA-BN) was recommended for at-risk populations in 2022, despite a scarcity of data on safety and effectiveness against mpox.
View Article and Find Full Text PDFJ Genet Couns
April 2025
Genetics Institute, Carmel Medical Center, Haifa, Israel.
This study aimed to evaluate the perceived quality of pre- and post-test explanations given to women carrying BRCA1/2 variants, and to compare these outcomes between two cohorts: female BRCA1/2 carriers identified through self-reported population-based screening (the screening group), in comparison to self-reported formal pre-test genetic counseling due to personal or familial cancer history (genetic counseling group). This cross-sectional survey of female BRCA1/2 carriers employed an anonymous questionnaire distributed through the "Good Genes - a support and information group for BRCA carriers" association from January to March 2023. Main evaluated outcomes included the perceived quality of pre- and post-test explanations, first analyzed in the overall cohort, and then compared between the 110 respondents in the screening group, to 444 women in the counseling group.
View Article and Find Full Text PDFClin Gastroenterol Hepatol
March 2025
Department of Gastroenterology, Rambam Health Care Campus, Haifa, Israel; B. Rappaport Faculty of Medicine, the Technion - Israel Institute of Technology, Haifa, Israel.
Background & Aims: In this nationwide cohort from Israel (Epi-IIRN), we aimed to characterize risks for age-related complications, mortality, and inflammatory bowel disease (IBD)-related surgeries in patients with elderly-onset IBD (EO-IBD).
Methods: Data of patients with EO-IBD (≥65 years) diagnosed during 2005 to 2020 were retrieved from the epi-IIRN database. Patients with EO-IBD were compared with 3 age-, sex-, and district-matched non-IBD individuals, for age-related outcomes.
Dig Dis Sci
March 2025
Innovation Division, Clalit Research Institute, Clalit Health Services, Tel Aviv, Israel.
Infect Dis Ther
February 2025
Clalit Community Division, Clalit Health Services, Tel Aviv, Israel.
Introduction: The effectiveness of AZD7442 (tixagevimab/cilgavimab) against COVID-19 hospitalizations was determined at 3 and 6 months among immunocompromised individuals in Israel during different variant circulations.
Methods: This was a retrospective cohort study using data from Clalit Health Services in Israel. Immunocompromised individuals eligible to receive AZD7442 300 mg between 15 February and 11 December 2022 were identified.
Integrating structured clinical knowledge into artificial intelligence (AI) models remains a major challenge. Medical codes primarily reflect administrative workflows rather than clinical reasoning, limiting AI models' ability to capture true clinical relationships and undermining their generalizability. To address this, we introduce , a clinical knowledge graph that integrates eight EHR-based vocabularies, and , a set of 153,166 clinical code embeddings derived from using a graph transformer neural network.
View Article and Find Full Text PDFJ Crohns Colitis
April 2025
Department of Gastroenterology, Rambam Health Care Campus, Haifa, Israel.
J Infect
December 2024
Ben-Gurion University of the Negev, Israel; Clalit Research Institute, Israel; The Ivan and Francesca Berkowitz Family Living Laboratory Collaboration at Harvard Medical School and Clalit Research Institute. Electronic address:
Background: Most studies that explore the long-term effects of COVID-19 are based on subjectively reported symptoms, while laboratory-measured biomarkers are mainly examined in studies of relatively small cohorts. This study investigates the long-term effects of SARS-CoV-2 infection on common laboratory biomarkers.
Methods: We utilized a retrospective cohort of SARS-CoV-2 infected individuals and rigorously matched controls based on demographic and clinical characteristics, examining 63 common laboratory biomarkers.
Int J Infect Dis
December 2024
Clalit Research Institute, Innovation Division, Clalit Health Services, Tel Aviv, Israel.
Objectives: Trivalent inactivated influenza vaccine effectiveness was low in a prospective cohort of healthcare personnel (HCP) in Israel from 2016 to 2019. We conducted a randomised immunogenicity trial of quadrivalent recombinant influenza vaccine (RIV4) and standard-dose inactivated influenza vaccine (IIV4) among frequently and infrequently vaccinated previous cohort participants.
Methods: From October 2019 to January 2020, we enrolled and randomly allocated HCP from two Israeli hospitals to receive IIV4 or RIV4.
J Crohns Colitis
February 2025
Pediatric Gastroenterology Institute, "Dana-Dwek" Children's Hospital, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Intern Emerg Med
November 2024
Heart Institute, Marom Medical Center, Kfar-Saba, Israel.
Despite progress in therapy, heart failure (HF) inflicts a heavy burden of hospital admissions. In this study, we identified among 1360 community-dwelling HF patients (mean age 70.7 ± 11.
View Article and Find Full Text PDFEuro Surveill
August 2024
Clalit Research Institute, Innovation Division, Clalit Health Services, Tel Aviv, Israel.
BackgroundHealthcare personnel (HCP) are at high risk for respiratory infections through occupational exposure to respiratory viruses.AimWe used data from a prospective influenza vaccine effectiveness study in HCP to quantify the incidence of acute respiratory infections (ARI) and their associated presenteeism and absenteeism.MethodsAt the start and end of each season, HCP at two Israeli hospitals provided serum to screen for antibodies to influenza virus using the haemagglutination inhibition assay.
View Article and Find Full Text PDFDatabase (Oxford)
July 2024
Clalit Research Institute, Clalit Health Services, Tuval 40, Ramat Gan 5252247, Israel.
Targeted gene panel sequencing is used to limit the search for causative genetic variants solely to genes with an established association with the phenotype. The design of gene panels is challenging due to the lack of consensus regarding phenotypic associations for some genes, which results in high variation in gene composition for the same panel offered by different laboratories. We developed PANGEN, a platform that provides a centralized resource for gene panel information, with the ability to compare and generate new intelligent diagnostic panels.
View Article and Find Full Text PDFVaccine
October 2024
Rabin Medical Center, Clalit Health Services, Petah Tikva, Israel.
Clin Cancer Res
August 2024
Division of Haematology Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada.
Replication repair deficiency (RRD) is a pan-cancer mechanism characterized by abnormalities in the DNA mismatch repair (MMR) system due to pathogenic variants in the PMS2, MSH6, MSH2, or MLH1 genes, and/or in the polymerase-proofreading genes POLE and POLD1. RRD predisposition syndromes (constitutional MMR deficiency, Lynch, and polymerase proofreading-associated polyposis) share overlapping phenotypic and biological characteristics. Moreover, cancers stemming from germline defects of one mechanism can acquire somatic defects in another, leading to complete RRD.
View Article and Find Full Text PDF